Spain Neurology Clinical Trials Market Size & Outlook
Related Markets
Spain neurology clinical trials market highlights
- The Spain neurology clinical trials market generated a revenue of USD 224.8 million in 2024 and is expected to reach USD 324.2 million by 2030.
- The Spain market is expected to grow at a CAGR of 6.4% from 2025 to 2030.
- In terms of segment, phase iii was the largest revenue generating phase in 2024.
- Phase I is the most lucrative phase segment registering the fastest growth during the forecast period.
Neurology clinical trials market data book summary
| Market revenue in 2024 | USD 224.8 million |
| Market revenue in 2030 | USD 324.2 million |
| Growth rate | 6.4% (CAGR from 2025 to 2030) |
| Largest segment | Phase iii |
| Fastest growing segment | Phase I |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Phase I, Phase II, Phase III, Phase IV |
| Key market players worldwide | Syneos Health, Icon PLC, AbbVie Inc, GlaxoSmithKline, Aurora Healthcare, Labcorp Drug Development, Pfizer Inc, AstraZeneca PLC, Biogen Inc, Eli Lilly and Co, Alzheon, BDD & Cie, Cognition Health Partners |
Other key industry trends
- In terms of revenue, Spain accounted for 3.9% of the global neurology clinical trials market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK neurology clinical trials market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 372.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neurology Clinical Trials Market Scope
Neurology Clinical Trials Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Cognition Health Partners | View profile | 11-50 | Panama City Beach, Florida, United States, North America | http://cognitionhealthpartners.com |
| BDD & Cie | View profile | 11-50 | Les Acacias, Geneve, Switzerland, Europe | https://www.bdd.ch |
| Alzheon | View profile | 11-50 | Framingham, Massachusetts, United States, North America | http://www.alzheon.com |
| Aurora Healthcare | View profile | 1001-5000 | Sydney, New South Wales, Australia, Oceania | https://aurorahealth.com.au |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| Syneos Health | View profile | 1001-5000 | Morrisville, North Carolina, United States, North America | https://www.syneoshealth.com/ |
| Labcorp Drug Development | View profile | 10001+ | Princeton, New Jersey, United States, North America | https://drugdevelopment.labcorp.com |
| Biogen Inc | View profile | 7570 | 225 Binney Street, Cambridge, MA, United States, 02142 | https://www.biogen.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Icon PLC | View profile | 41150 | South County Business Park, Leopardstown, Dublin, Ireland, D18 X5R3 | https://www.iconplc.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Spain neurology clinical trials market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neurology clinical trials market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 45.55% in 2024. Horizon Databook has segmented the Spain neurology clinical trials market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Spain neurology clinical trials market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Spain neurology clinical trials market databook
-
Our clientele includes a mix of neurology clinical trials market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain neurology clinical trials market , including forecasts for subscribers. This country databook contains high-level insights into Spain neurology clinical trials market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Spain Phase - Neurology Clinical Trials Market size, 2024 - 2030 (US$M)
Spain Neurology Clinical Trials Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
